Founding Member

Pan-European umbrella organisation of national and regional cancer societies

Founding Member

Think-tank and NGO pioneering psychedelic research to discover and explore new avenues for the treatment of illnesses and drive evidence-based drug policy reform

Founding Member

Network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners

Founding Member

Scientific association dedicated to the science and treatment of disorders of the brain and the largest non-institutional supporter of applied and translational neuroscience research and education in Europe

Founding Member

Brings together European umbrella organisations of neurological patient advocacy groups

With active individual members in 88 countries and 44 National Psychiatric Association Members who represent more than 78,000 European psychiatrists, EPA is the main association representing psychiatry in Europe. The EPA focuses on the improvement of care for the mentally ill as well as on the development of professional excellence.

Founding Member

Independent, science-led drugs charity, bringing together leading drugs experts from a wide range of specialisms to carry out ground-breaking research into drug harms and effects

Founding Member

GAMIAN Europe is a patient-driven pan-European organisation, representing and advocating for the interests and rights of persons affected by mental ill-health.

European non-profit science and education organization that promotes psychedelic research and therapy by building on the neurobiological and psychological potential of psychedelics to improve mental health and well-being in a clinical setting.

Founding Member

Leading nonprofit organisation dedicated to advancing psychedelic research and therapies.

Founding Member

A non-profit organisation focused on supporting psychedelic research through fundraising, grant opportunities and education.

Founding Member

Belgium based patient umbrella organisation of 40 national and regional associations in 17 European countries, concerned with chronic pain, regardless the underlying condition.

A network of psychedelic clinical trial and treatment participants, providing mutual peer support and a strong participant voice to help establish a model of best practice across the global psychedelic sector

Heroic Hearts helps connect UK military and emergency services veterans with psychedelic therapy retreat centres in countries where such practices are legal.

SPACE is a Portuguese scientific association formed in 2021 by a group of psychiatry doctors with the primary mission of studying, disseminating and promoting knowledge about the potential therapeutic uses of psychedelic substances.

French Psychedelic Society is a hub of young researchers and students interested in research collaboration on psychedelics, an association for scientific and cultural mediation, and a community of users who share a spirit of responsibility and harm reduction.

Organising events and conferences that aim to allow clinicians and researchers to acquire and deepen their knowledge about the present psychedelic literature in this domain and its future developments.

CDPRG is an evidence-based policy forum which promotes informed debate on drug policy reform. It aims to draw the attention of the centre-right to the injustices and inadequacies of existing drug policy.

PPS popularizes and supports scientific research on psychedelic substances and provides space for essential debate regarding their potential application in science, medicine, psychotherapy and culture.

PSB promotes and funds research in Belgium, in cooperation with Flemish and French speaking universities. It engages with policymakers to legally regulate the use of psychedelics for the treatment of different conditions.

Kykeon works towards the destigmatization of psychedelics in Greece through community building, disseminating educational resources, providing a platform for knowledge-sharing and interdisciplinary dialogue on the therapeutic use of psychedelics and advocating for drug policy reform.

A not-for-profit, UK-based organisation, focusing on cultivating the psychedelic community and

delivering education about the safe and responsible use of psychedelics.

The Institute of Psychedelic Therapy, HoloMind, is a Polish initiative designed to educate about the therapeutic use of psychedelics, as well as to advocate for and lobby in favour of psychedelic treatments in Poland.

IPT aims to support the professional development of this field, deepen practitioner capacity in assisting expanded states in a therapeutic manner and develop robust ethical guidelines to support safe and skilful practice.

SEMPsi comprises medical doctors, psychologists and researchers in the field of mental health. Its goal is to promote evidence-based therapeutic use and research with psychedelic substances, within an ethical, scientific and culturally respectful context.

Fundación inawe is a non-profit organization that promotes innovation in mental health through the development of an ecosystem that facilitates the implementation of Psychedelic-Assisted Therapies in Spain.

TAIP is an Estonian organisation that advances science-based approaches to using psychedelics in contemporary therapeutic practices.

UPRA is a place where academics, clinicians, patients and activists meet for advancing legal therapeutic use and scientific research of psychedelics in Ukraine.

SIMEPSI is a multidisciplinary, non-profit organization working to promote scientific research, raise cultural awareness, and develop regulatory frameworks for safe psychedelic treatments while facilitating knowledge exchange and public education in Italy.